|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
153 |
$52,082.73 |
2.75% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,264 |
$50,182.56 |
2.65% |
| LivaNova Plc |
LIVN |
G5509L101 |
627 |
$50,128.65 |
2.64% |
| Baxter International Inc. |
BAX |
071813109 |
2,294 |
$48,265.76 |
2.55% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
368 |
$47,491.17 |
2.50% |
| Revvity, Inc. |
RVTY |
714046109 |
438 |
$46,265.94 |
2.44% |
| Waters Corporation |
WAT |
941848103 |
123 |
$45,409.14 |
2.40% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
505 |
$45,278.30 |
2.39% |
| Agilent Technologies, Inc. |
A |
00846U101 |
342 |
$45,017.46 |
2.37% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,385 |
$43,103.96 |
2.27% |
| DexCom, Inc. |
DXCM |
252131107 |
614 |
$42,826.50 |
2.26% |
| Teleflex Incorporated |
TFX |
879369106 |
332 |
$42,001.32 |
2.22% |
| Olympus Corporation |
7733.JP |
J61240107 |
4,040 |
$41,054.07 |
2.17% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,293 |
$40,751.66 |
2.15% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
170 |
$40,552.37 |
2.14% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,960 |
$39,947.10 |
2.11% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
576 |
$39,859.20 |
2.10% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
141 |
$39,487.05 |
2.08% |
| Danaher Corporation |
DHR |
235851102 |
207 |
$39,096.09 |
2.06% |
| Align Technology, Inc. |
ALGN |
016255101 |
227 |
$38,794.30 |
2.05% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
79 |
$38,883.80 |
2.05% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,534 |
$38,271.31 |
2.02% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
422 |
$38,216.32 |
2.02% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
197 |
$37,843.74 |
2.00% |
| The Cooper Companies, Inc. |
COO |
216648501 |
552 |
$37,994.16 |
2.00% |
| Becton, Dickinson and Company |
BDX |
075887109 |
255 |
$37,681.35 |
1.99% |
| Penumbra, Inc. |
PEN |
70975L107 |
119 |
$37,646.84 |
1.99% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,382 |
$37,092.23 |
1.96% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,744 |
$36,914.96 |
1.95% |
| Steris Plc |
STE |
G8473T100 |
177 |
$36,669.09 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
116 |
$36,386.88 |
1.92% |
| Medtronic Plc |
MDT |
G5960L103 |
451 |
$36,138.63 |
1.91% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
30 |
$36,095.40 |
1.90% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
435 |
$35,722.20 |
1.88% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,344 |
$35,555.38 |
1.88% |
| Abbott Laboratories |
ABT |
002824100 |
392 |
$35,472.08 |
1.87% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
538 |
$34,905.44 |
1.84% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
87 |
$34,959.21 |
1.84% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
888 |
$34,510.20 |
1.82% |
| Alcon Inc. |
ALC.SW |
H01301128 |
504 |
$34,337.85 |
1.81% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
585 |
$33,674.04 |
1.78% |
| ResMed Inc. |
RMD |
761152107 |
172 |
$33,798.00 |
1.78% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
11,000 |
$32,773.63 |
1.73% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$31,588.09 |
1.67% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
343 |
$31,641.75 |
1.67% |
| Insulet Corporation |
PODD |
45784P101 |
200 |
$29,776.00 |
1.57% |
| BioMerieux |
BIM.FP |
F1149Y232 |
372 |
$28,783.02 |
1.52% |
| Boston Scientific Corporation |
BSX |
101137107 |
637 |
$28,321.02 |
1.49% |
| Cochlear Limited |
COH.AU |
Q25953102 |
323 |
$25,257.15 |
1.33% |
| US Dollar |
$USD |
|
10,493 |
$10,493.49 |
0.55% |
| Japanese Yen |
$JPY |
|
91,571 |
$565.88 |
0.03% |
| New Zealand Dollar |
$NZD |
|
679 |
$383.88 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.14 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|